Sisram Medical Ltd. disclosed its Monthly Return for Equity Issuers for the period ended 30 September 2026, confirming that both its authorised and issued share capital remained unchanged during the month.

Authorised Capital • The company’s authorised share capital stood at 1.00 billion ordinary shares with a par value of ILS 0.01 each, equivalent to ILS 10.00 million. • No additions or reductions were recorded, leaving total authorised capital intact at ILS 10.00 million.

Issued and Treasury Shares • Outstanding shares stayed at 468.34 million, and Sisram Medical held no treasury shares. • There were no share issuances, repurchases, cancellations, or transfers in September, resulting in a stable issued share count of 468.34 million.

Capital Instruments • The filing shows no movements or outstanding balances in share options, warrants, convertible securities, or other equity-linked instruments.

Public Float • Sisram Medical affirmed compliance with Hong Kong Main Board Rule 13.32D(1), maintaining at least the mandatory 25 percent public float requirement.

Administrative Details • The Monthly Return was submitted on 5 October 2026 by Company Secretary Qianli Fang.

With no equity-related activities reported for the month, Sisram Medical’s capital structure and shareholder distribution remain steady heading into the final quarter of 2026.